Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,766 | 139 | 99.0% |
| Education | $27.74 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $404.50 | 27 | $0 (2024) |
| Allergan, Inc. | $365.77 | 16 | $0 (2022) |
| CooperVision Inc. | $301.05 | 10 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $288.44 | 16 | $0 (2021) |
| Oyster Point Pharma, Inc. | $228.54 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $193.44 | 13 | $0 (2023) |
| ABBVIE INC. | $179.66 | 9 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $146.91 | 8 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $124.67 | 3 | $0 (2022) |
| Johnson & Johnson Vision Care, Inc. | $114.96 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $312.61 | 15 | Bausch & Lomb Americas Inc. ($76.29) |
| 2023 | $417.70 | 18 | Oyster Point Pharma, Inc. ($169.04) |
| 2022 | $728.98 | 33 | Alcon Vision LLC ($187.63) |
| 2021 | $398.06 | 23 | Alcon Vision LLC ($82.30) |
| 2020 | $193.35 | 11 | Allergan, Inc. ($46.70) |
| 2019 | $278.87 | 16 | Bausch & Lomb, a division of Bausch Health US, LLC ($100.14) |
| 2018 | $299.93 | 16 | Allergan Inc. ($82.74) |
| 2017 | $164.08 | 9 | Valeant Pharmaceuticals North America LLC ($47.64) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $19.57 | General |
| 11/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Alcon Vision LLC | Precision 1 (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Ophthalmology | ||||||
| 10/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/07/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Dry eyes | ||||||
| 07/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| 06/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/31/2024 | Bausch & Lomb Americas Inc. | INFUSE, BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $23.41 | General |
| 05/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: EYE CARE | ||||||
| 04/29/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 04/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/06/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Devices | ||||||
| 02/06/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Ophthalmology | ||||||
| 01/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: EYE CARE | ||||||
| 11/30/2023 | Bausch & Lomb Americas Inc. | BIOTRUE ONE DAY, INFUSE | Food and Beverage | In-kind items and services | $18.15 | General |
| 11/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: DRY EYE | ||||||
| 11/15/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: EYE CARE | ||||||
| 10/23/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: DRY EYE | ||||||
| 10/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: DRY EYE | ||||||
| 09/08/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Ophthalmology | ||||||
| 09/05/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Ophthalmology | ||||||
| 07/26/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: EYE CARE | ||||||
| 06/08/2023 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Soft Contact Lenses | ||||||
| 05/25/2023 | Alcon Vision LLC | Precision 1 (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 270 | 301 | $39,875 | $15,758 |
| 2022 | 7 | 286 | 303 | $37,342 | $14,330 |
| 2021 | 5 | 276 | 308 | $37,060 | $14,706 |
| 2020 | 9 | 468 | 523 | $63,080 | $23,557 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 94 | 95 | $15,240 | $7,456 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 59 | $6,657 | $3,295 | 49.5% |
| 92250 | Photography of the retina | Office | 2023 | 79 | 83 | $10,644 | $1,969 | 18.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 35 | 37 | $3,950 | $1,537 | 38.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 12 | 12 | $2,096 | $1,151 | 54.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 11 | 15 | $1,288 | $349.77 | 27.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 93 | 93 | $13,965 | $6,454 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 59 | $6,195 | $3,361 | 54.2% |
| 92250 | Photography of the retina | Office | 2022 | 85 | 86 | $10,332 | $1,851 | 17.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 14 | 14 | $2,240 | $1,133 | 50.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 25 | 26 | $2,610 | $1,023 | 39.2% |
| 92134 | Imaging of retina | Office | 2022 | 12 | 12 | $960.00 | $285.34 | 29.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 12 | 13 | $1,040 | $223.23 | 21.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 91 | 91 | $13,650 | $6,633 | 48.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 74 | $7,770 | $4,182 | 53.8% |
| 92250 | Photography of the retina | Office | 2021 | 80 | 87 | $10,440 | $2,015 | 19.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 35 | 36 | $3,600 | $1,398 | 38.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 18 | 20 | $1,600 | $479.28 | 30.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 129 | 130 | $19,500 | $9,488 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 96 | $10,080 | $4,257 | 42.2% |
| 92250 | Photography of the retina | Office | 2020 | 124 | 134 | $16,080 | $3,317 | 20.6% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 57 | 61 | $6,100 | $2,392 | 39.2% |
| 66984 | Removal of cataract with insertion of lens | Office | 2020 | 13 | 19 | $3,800 | $1,470 | 38.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 12 | 12 | $1,920 | $913.56 | 47.6% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 30 | 34 | $2,720 | $798.07 | 29.3% |
About Dr. Brian Beissel, OD
Dr. Brian Beissel, OD is a Optometrist healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417048430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Beissel, OD has received a total of $2,794 in payments from pharmaceutical and medical device companies, with $312.61 received in 2024. These payments were reported across 141 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,766).
As a Medicare-enrolled provider, Beissel has provided services to 1,300 Medicare beneficiaries, totaling 1,435 services with total Medicare billing of $68,351. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Lansing, MI
- Active Since 09/27/2006
- Last Updated 07/09/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1417048430
Products in Payments
- XIIDRA (Drug) $240.92
- DAILIES (Device) $238.16
- TYRVAYA (Drug) $228.54
- LUMIGAN (Drug) $206.48
- VYZULTA (Drug) $202.17
- Precision 1 (Device) $181.12
- Clariti Contact Lens (Device) $171.33
- RESTASIS MULTIDOSE (Drug) $150.50
- MyDay Contact Lens (Device) $129.72
- Cequa (Drug) $124.67
- Acuvue (Device) $114.96
- VUITY (Drug) $91.32
- INVELTYS (Drug) $83.92
- RESTASIS (Drug) $78.48
- XDEMVY (Drug) $75.43
- MIEBO (Drug) $52.88
- TOTAL30 (Device) $52.25
- ULTRA (Device) $46.20
- BIOTRUE ONE DAY (Device) $39.40
- PAZEO (Drug) $28.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lansing
Dr. Samuel Estes, O.d, O.D
Optometrist — Payments: $5,094
Paul Kennedy, Od, OD
Optometrist — Payments: $3,021
Dr. Jeffrey Rule, Od, OD
Optometrist — Payments: $1,891
Dr. Richard Rule, O.d. P.c, O.D. P.C
Optometrist — Payments: $1,701
Dr. Laurey Schillman, O.d, O.D
Optometrist — Payments: $1,540
Jamie Shay, Od, OD
Optometrist — Payments: $1,502